severe diarrhea on tirzepatide vs. Semaglutide: What You Should Know Lilly releases Zepbound® (tirzepatide) single-dose
Description
During this, your medical history and health goals are examined, setting the foundation for a custom treatment plan
Obesity is a major contributor to degenerative spine disease, knee osteoarthritis, and chronic musculoskeletal pain
Semaglutide (Wegovy, Ozempic) received FDA approval for chronic weight management in 2021, followed by tirzepatide (Zepbound) in 2023, both demonstrating substantial weight loss in clinical trials
It is prescribed to also help prevent migraine headaches in adults
Two years ago, one of these drugs, semaglutide, also was approved as an obesity treatment in the U.S., sparking an explosion in public interest
